|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-2-27
|
|
pubmed:abstractText |
Corticosteroids are considered to be particularly effective in reducing nasal congestion and are therefore recommended as first-line treatment in allergic rhinitis patients with moderate to severe and/or persistent symptoms.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetates,
http://linkedlifedata.com/resource/pubmed/chemical/Androstadienes,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Cetirizine,
http://linkedlifedata.com/resource/pubmed/chemical/Eosinophil Granule Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine H1 Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Leukotriene Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines,
http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleases,
http://linkedlifedata.com/resource/pubmed/chemical/fluticasone,
http://linkedlifedata.com/resource/pubmed/chemical/montelukast
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0954-7894
|
|
pubmed:author |
pubmed-author:CandoreGG,
pubmed-author:CarusoCC,
pubmed-author:CorrocherRR,
pubmed-author:Di GregoliAA,
pubmed-author:Di LorenzoGG,
pubmed-author:DittaVV,
pubmed-author:Lo BiancoCC,
pubmed-author:MansuetoPP,
pubmed-author:MartinelliNN,
pubmed-author:MoriciGG,
pubmed-author:PacorM LML,
pubmed-author:PellitteriM EME,
pubmed-author:RiniG BGB
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
259-67
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14987306-Acetates,
pubmed-meshheading:14987306-Administration, Intranasal,
pubmed-meshheading:14987306-Adolescent,
pubmed-meshheading:14987306-Adult,
pubmed-meshheading:14987306-Analysis of Variance,
pubmed-meshheading:14987306-Androstadienes,
pubmed-meshheading:14987306-Blood Proteins,
pubmed-meshheading:14987306-Cetirizine,
pubmed-meshheading:14987306-Child,
pubmed-meshheading:14987306-Double-Blind Method,
pubmed-meshheading:14987306-Drug Administration Schedule,
pubmed-meshheading:14987306-Drug Therapy, Combination,
pubmed-meshheading:14987306-Eosinophil Granule Proteins,
pubmed-meshheading:14987306-Female,
pubmed-meshheading:14987306-Glucocorticoids,
pubmed-meshheading:14987306-Histamine H1 Antagonists,
pubmed-meshheading:14987306-Humans,
pubmed-meshheading:14987306-Leukotriene Antagonists,
pubmed-meshheading:14987306-Male,
pubmed-meshheading:14987306-Middle Aged,
pubmed-meshheading:14987306-Quinolines,
pubmed-meshheading:14987306-Rhinitis, Allergic, Seasonal,
pubmed-meshheading:14987306-Ribonucleases
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
|
|
pubmed:affiliation |
Dipartimento di Medicina Clinica e delle Patologie Emergenti, Università di Palermo, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
